"GlycoVision results featured at ESMO 2024: read the interview here to learn how InterVenn is powering new prognostic and predictive biomarkers!
Back to blog list
June 15, 2022
Peripheral Blood Glycoproteomic Biomarkers As A Powerful New Tool For The Detection Of Nasopharyngeal Carcinoma

Get in touch